Literature DB >> 8972004

Application of HUMF13A01 (AAAG)n STR polymorphism to the genetic diagnosis of coagulation factor XIII deficiency.

S Kangsadalampai1, M Coggan, S H Caglayan, G Aktuglu, P G Board.   

Abstract

Deficiency of the A subunit of coagulation factor XIII causes a severe bleeding disorder requiring life long replacement therapy. The mutations causing A subunit deficiency appear to be very heterogeneous, and it is impractical to identify each mutation before genetic counselling or prenatal diagnosis can be attempted. In this study we have shown that a highly polymorphic short tandem repeat element, HUMF13A01 (AAAG)n that occurs in the 5' flanking sequence of the factor XIII A subunit gene, can be used to follow the segregation of deficiency causing mutations. We studied 6 families with factor XIII A subunit deficiency from 5 different ethnic groups. All parents were heterozygous for the repetitive element and therefore all the families were informative. The linked polymorphism was used to carry out the first prenatal diagnosis of factor XIII A subunit deficiency. The analysis of this polymorphism by the polymerase chain reaction is rapid, reliable, requires little DNA and is ideal for the genetic analysis of factor XIII A subunit deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972004

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Prenatal diagnosis in factor XIII-A deficiency.

Authors:  C J Killick; C J Barton; S Aslam; G Standen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 2.  How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.

Authors:  Hojat Shahraki; Akbar Dorgalaleh; Majid Fathi; Shadi Tabibian; Shahram Teimourian; Hasan Mollanoori; Alireza Khiabani; Farhad Zaker
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.